Sigachi Industries (SIGACHI) Stock Overview
Manufactures and sells microcrystalline cellulose and cellulose powder in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
SIGACHI Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.Read more
Sigachi Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹23.33 |
| 52 Week High | ₹59.59 |
| 52 Week Low | ₹16.65 |
| Beta | 0.31 |
| 1 Month Change | 25.63% |
| 3 Month Change | -15.07% |
| 1 Year Change | -44.52% |
| 3 Year Change | -5.49% |
| 5 Year Change | n/a |
| Change since IPO | -61.02% |
Recent News & Updates
Recent updates
Slammed 29% Sigachi Industries Limited (NSE:SIGACHI) Screens Well Here But There Might Be A Catch
Jan 21
Sigachi Industries Limited (NSE:SIGACHI) Stock Rockets 26% But Many Are Still Ignoring The Company
Oct 04Sigachi Industries' (NSE:SIGACHI) Shareholders May Want To Dig Deeper Than Statutory Profit
Jun 10Sigachi Industries Limited's (NSE:SIGACHI) Share Price Is Matching Sentiment Around Its Earnings
Apr 05These 4 Measures Indicate That Sigachi Industries (NSE:SIGACHI) Is Using Debt Reasonably Well
Jan 13Sigachi Industries Limited's (NSE:SIGACHI) Share Price Is Matching Sentiment Around Its Earnings
Oct 23Sigachi Industries' (NSE:SIGACHI) Shareholders May Want To Dig Deeper Than Statutory Profit
Jun 03Sigachi Industries Limited's (NSE:SIGACHI) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Mar 17There's Reason For Concern Over Sigachi Industries Limited's (NSE:SIGACHI) Massive 44% Price Jump
Jan 21Sigachi Industries' (NSE:SIGACHI) Solid Earnings May Rest On Weak Foundations
May 21Sigachi Industries Limited's (NSE:SIGACHI) 25% Share Price Plunge Could Signal Some Risk
Mar 08Shareholder Returns
| SIGACHI | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 12.0% | 2.3% | 2.7% |
| 1Y | -44.5% | 4.0% | 5.0% |
Return vs Industry: SIGACHI underperformed the Indian Pharmaceuticals industry which returned 4% over the past year.
Return vs Market: SIGACHI underperformed the Indian Market which returned 5% over the past year.
Price Volatility
| SIGACHI volatility | |
|---|---|
| SIGACHI Average Weekly Movement | 10.3% |
| Pharmaceuticals Industry Average Movement | 6.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in IN Market | 10.4% |
| 10% least volatile stocks in IN Market | 4.8% |
Stable Share Price: SIGACHI's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: SIGACHI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 1,507 | Amit Sinha | sigachi.com |
Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India. The company offers cellulose-based products under the HiCel, AceCel, CoatCel, GloCel, and BARETab names; and various chemicals, including colloidal silicon dioxide, carboxy cellulose sodium and mannitol, etc. to active pharmaceutical ingredients, food and nutrition, cosmetic, and chemical industries. It also provides operations and maintenance services in the fields of speciality chemicals, petrochemicals, water treatment, and pharmaceuticals.
Sigachi Industries Limited Fundamentals Summary
| SIGACHI fundamental statistics | |
|---|---|
| Market cap | ₹8.91b |
| Earnings (TTM) | -₹762.02m |
| Revenue (TTM) | ₹4.85b |
Is SIGACHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIGACHI income statement (TTM) | |
|---|---|
| Revenue | ₹4.85b |
| Cost of Revenue | ₹2.43b |
| Gross Profit | ₹2.41b |
| Other Expenses | ₹3.18b |
| Earnings | -₹762.02m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.99 |
| Gross Margin | 49.78% |
| Net Profit Margin | -15.72% |
| Debt/Equity Ratio | 32.2% |
How did SIGACHI perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/16 18:10 |
| End of Day Share Price | 2026/04/16 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sigachi Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.